Heartflow, Inc. Selling, General and Administrative Expense
Heartflow, Inc. (HTFL) reported Selling, General and Administrative Expense of $44.83 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-13
- Heartflow, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $44.83M, a 42.49% increase year-over-year.
- Heartflow, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $42.57M, a 35.05% increase year-over-year.
- Heartflow, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $38.15M, a 27.04% increase year-over-year.
- Heartflow, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $33.22M, a 18.62% increase year-over-year.
- Heartflow, Inc. selling, general and administrative expense for fiscal 2025 was $134.34M, a 19.79% increase from fiscal 2024.
- Heartflow, Inc. selling, general and administrative expense for fiscal 2024 was $112.15M, a 17.92% increase from fiscal 2023.
- Heartflow, Inc. selling, general and administrative expense for fiscal 2023 was $95.11M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $44.83M 10-Q · filed 2026-08-13 | $87.39M 10-Q · filed 2026-08-13 | $125.54M derived: sum of 3 quarters · filed 2026-08-13 | $158.76M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $42.57M 10-Q · filed 2026-05-14 | $80.71M derived: sum of 2 quarters · filed 2026-05-14 | $113.93M derived: sum of 3 quarters · filed 2026-05-14 | $145.39M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $38.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $71.36M derived: sum of 2 quarters · filed 2026-03-18 | $102.83M derived: sum of 3 quarters · filed 2026-08-13 | $134.34M 10-K · filed 2026-03-18 |
| 2025-09-30 | $33.22M 10-Q · filed 2025-11-12 | $64.68M derived: sum of 2 quarters · filed 2026-08-13 | $96.20M 10-Q · filed 2025-11-12 | $126.23M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $31.46M 10-Q · filed 2026-08-13 | $62.98M 10-Q · filed 2026-08-13 | $93.01M derived: sum of 3 quarters · filed 2026-08-13 | $121.01M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $31.52M 10-Q · filed 2026-05-14 | $61.55M derived: sum of 2 quarters · filed 2026-05-14 | $89.55M derived: sum of 3 quarters · filed 2026-05-14 | $117.64M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $30.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $58.03M derived: sum of 2 quarters · filed 2026-03-18 | $86.12M derived: sum of 3 quarters · filed 2026-03-18 | $112.15M 10-K · filed 2026-03-18 |
| 2024-09-30 | $28.00M 10-Q · filed 2025-11-12 | $56.09M derived: sum of 2 quarters · filed 2025-11-12 | $82.13M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $28.08M 10-Q · filed 2025-09-19 | $54.12M 10-Q · filed 2025-09-19 | ||
| 2023-12-31 | $95.11M 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |